- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Nanopharmaceuticals market will register a 13.5% CAGR in terms of revenue, the global market size will reach $ 38980 million by 2025, from $ 23500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nanopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanopharmaceuticals market by type, application, key manufacturers and key regions and countries.
This study considers the Nanopharmaceuticals value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Johnson & Johnson
Pfizer
Abbott
GlaxoSmithKline
Novartis
Eli Lilly
Roche
Astrazeneca
Sanofi
Kadmon Pharmaceuticals
Mitsubishi Pharma
Samyang Biopharm
Celgene
Gilead Sciences
Stryker
Selecta Biosciences
OSI Pharmaceuticals
Novavax
Kaken Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Par Pharmaceutical
Lummy
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nanopharmaceuticals consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nanopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Nanopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nanopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanopharmaceuticals Consumption 2015-2025
2.1.2 Nanopharmaceuticals Consumption CAGR by Region
2.2 Nanopharmaceuticals Segment by Type
2.2.1 Liposomes
2.2.2 Polymeric Micelles
2.2.3 Solid Lipid Nanoparticles
2.2.4 Microemulsion and Nnanoemulsion
2.2.5 Nanosuspension
2.3 Nanopharmaceuticals Consumption by Type
2.3.1 Global Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
2.3.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2015-2020)
2.3.3 Global Nanopharmaceuticals Sale Price by Type (2015-2020)
2.4 Nanopharmaceuticals Segment by Application
2.4.1 Cancer and Tumor
2.4.2 Autoimmune Disorders
2.4.3 Inflammation
2.4.4 Others
2.5 Nanopharmaceuticals Consumption by Application
2.5.1 Global Nanopharmaceuticals Consumption Market Share by Type (2015-2020)
2.5.2 Global Nanopharmaceuticals Value and Market Share by Type (2015-2020)
2.5.3 Global Nanopharmaceuticals Sale Price by Type (2015-2020)
3 Global Nanopharmaceuticals by Company
3.1 Global Nanopharmaceuticals Sales Market Share by Company
3.1.1 Global Nanopharmaceuticals Sales by Company (2018-2020)
3.1.2 Global Nanopharmaceuticals Sales Market Share by Company (2018-2020)
3.2 Global Nanopharmaceuticals Revenue Market Share by Company
3.2.1 Global Nanopharmaceuticals Revenue by Company (2018-2020)
3.2.2 Global Nanopharmaceuticals Revenue Market Share by Company (2018-2020)
3.3 Global Nanopharmaceuticals Sale Price by Company
3.4 Global Nanopharmaceuticals Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Nanopharmaceuticals Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Nanopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Nanopharmaceuticals by Regions
4.1 Nanopharmaceuticals by Regions
4.2 Americas Nanopharmaceuticals Consumption Growth
4.3 APAC Nanopharmaceuticals Consumption Growth
4.4 Europe Nanopharmaceuticals Consumption Growth
4.5 Middle East & Africa Nanopharmaceuticals Consumption Growth
5 Americas
5.1 Americas Nanopharmaceuticals Consumption by Countries
5.1.1 Americas Nanopharmaceuticals Consumption by Countries (2015-2020)
5.1.2 Americas Nanopharmaceuticals Value by Countries (2015-2020)
5.2 Americas Nanopharmaceuticals Consumption by Type
5.3 Americas Nanopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nanopharmaceuticals Consumption by Regions
6.1.1 APAC Nanopharmaceuticals Consumption by Regions (2015-2020)
6.1.2 APAC Nanopharmaceuticals Value by Regions (2015-2020)
6.2 APAC Nanopharmaceuticals Consumption by Type
6.3 APAC Nanopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nanopharmaceuticals by Countries
7.1.1 Europe Nanopharmaceuticals Consumption by Countries (2015-2020)
7.1.2 Europe Nanopharmaceuticals Value by Countries (2015-2020)
7.2 Europe Nanopharmaceuticals Consumption by Type
7.3 Europe Nanopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nanopharmaceuticals by Countries
8.1.1 Middle East & Africa Nanopharmaceuticals Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Nanopharmaceuticals Value by Countries (2015-2020)
8.2 Middle East & Africa Nanopharmaceuticals Consumption by Type
8.3 Middle East & Africa Nanopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nanopharmaceuticals Distributors
10.3 Nanopharmaceuticals Customer
11 Global Nanopharmaceuticals Market Forecast
11.1 Global Nanopharmaceuticals Consumption Forecast (2021-2025)
11.2 Global Nanopharmaceuticals Forecast by Regions
11.2.1 Global Nanopharmaceuticals Forecast by Regions (2021-2025)
11.2.2 Global Nanopharmaceuticals Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Nanopharmaceuticals Forecast by Type
11.8 Global Nanopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Merck
12.1.1 Company Information
12.1.2 Nanopharmaceuticals Product Offered
12.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merck Latest Developments
12.2 Johnson & Johnson
12.2.1 Company Information
12.2.2 Nanopharmaceuticals Product Offered
12.2.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Johnson & Johnson Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Nanopharmaceuticals Product Offered
12.3.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Abbott
12.4.1 Company Information
12.4.2 Nanopharmaceuticals Product Offered
12.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Abbott Latest Developments
12.5 GlaxoSmithKline
12.5.1 Company Information
12.5.2 Nanopharmaceuticals Product Offered
12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Nanopharmaceuticals Product Offered
12.6.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Eli Lilly
12.7.1 Company Information
12.7.2 Nanopharmaceuticals Product Offered
12.7.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Eli Lilly Latest Developments
12.8 Roche
12.8.1 Company Information
12.8.2 Nanopharmaceuticals Product Offered
12.8.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Roche Latest Developments
12.9 Astrazeneca
12.9.1 Company Information
12.9.2 Nanopharmaceuticals Product Offered
12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Astrazeneca Latest Developments
12.10 Sanofi
12.10.1 Company Information
12.10.2 Nanopharmaceuticals Product Offered
12.10.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sanofi Latest Developments
12.11 Kadmon Pharmaceuticals
12.11.1 Company Information
12.11.2 Nanopharmaceuticals Product Offered
12.11.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Kadmon Pharmaceuticals Latest Developments
12.12 Mitsubishi Pharma
12.12.1 Company Information
12.12.2 Nanopharmaceuticals Product Offered
12.12.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Mitsubishi Pharma Latest Developments
12.13 Samyang Biopharm
12.13.1 Company Information
12.13.2 Nanopharmaceuticals Product Offered
12.13.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Samyang Biopharm Latest Developments
12.14 Celgene
12.14.1 Company Information
12.14.2 Nanopharmaceuticals Product Offered
12.14.3 Celgene Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Celgene Latest Developments
12.15 Gilead Sciences
12.15.1 Company Information
12.15.2 Nanopharmaceuticals Product Offered
12.15.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Gilead Sciences Latest Developments
12.16 Stryker
12.16.1 Company Information
12.16.2 Nanopharmaceuticals Product Offered
12.16.3 Stryker Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Stryker Latest Developments
12.17 Selecta Biosciences
12.17.1 Company Information
12.17.2 Nanopharmaceuticals Product Offered
12.17.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Selecta Biosciences Latest Developments
12.18 OSI Pharmaceuticals
12.18.1 Company Information
12.18.2 Nanopharmaceuticals Product Offered
12.18.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 OSI Pharmaceuticals Latest Developments
12.19 Novavax
12.19.1 Company Information
12.19.2 Nanopharmaceuticals Product Offered
12.19.3 Novavax Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Novavax Latest Developments
12.20 Kaken Pharmaceutical
12.20.1 Company Information
12.20.2 Nanopharmaceuticals Product Offered
12.20.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Kaken Pharmaceutical Latest Developments
12.21 Cerulean Pharma
12.21.1 Company Information
12.21.2 Nanopharmaceuticals Product Offered
12.21.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Cerulean Pharma Latest Developments
12.22 Navidea Biopharmaceuticals
12.22.1 Company Information
12.22.2 Nanopharmaceuticals Product Offered
12.22.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Navidea Biopharmaceuticals Latest Developments
12.23 Par Pharmaceutical
12.23.1 Company Information
12.23.2 Nanopharmaceuticals Product Offered
12.23.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Par Pharmaceutical Latest Developments
12.24 Lummy
12.24.1 Company Information
12.24.2 Nanopharmaceuticals Product Offered
12.24.3 Lummy Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Lummy Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Nanopharmaceuticals Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
